// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Long-term benefits of pulmonary rehabilitation in COPD patients: 2 year follow-up

Abebaw Yohannes - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Anxiety

N/A

A multicentre randomised controlled trial of inspiratory muscle training for patients with chronic obstructive pulmonary disease (IMTCO study)

Noppawan Charususin - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

The effect of an acute exacerbation of COPD (AECOPD) on balance after pulmonary rehabilitation (PR): a prospective study

Samantha Harrison - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

Non-invasive ventilation for the management of acute hypercapnic respiratory failure due to exacerbation of chronic obstructive pulmonary disease: a Cochrane review update

Christian Osadnik - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

The survival effect of physical activity in patients with COPD: every step counts

Heleen Demeyer - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

Carbetimer

Relationship between muscle mass and function and physical activity levels in patients with COPD – a longitudinal study

Leandro Mantoani - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

Equalisation of negative intra-pleural pressure via Tunnelled Pleural Catheters (TPCs): a novel practice

Alexandra Ewence - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Mesothelioma

N/A

Tunnelled indwelling pleural catheters and trapped lung in malignant mesothelioma

Yasser Madani - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Mesothelioma

N/A

Inflammatory appearance of the parietal pleura at thoracoscopy – what does it hide?

Yasser Madani - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Utility of conjoined EBUS-TBNA, ROSE (rapid-on site evaluation) and flow cytometry in diagnosis of lymphoma

Miras Medenica - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Lymphomas

N/A

Comparison of multiple serum and pleural fluid biomarkers for the diagnosis of Malignant Pleural Mesothelioma

Daniel Neville - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Malignant pleural mesothelioma

N/A

Prognostic role of inflammatory cells in blood, pleural fluid and tumour samples, in patients with malignant pleural mesothelioma (MPM)

Duneesha De Fonseka - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Malignant pleural mesothelioma

N/A

Retrospective analysis of survival time in malignant pleural effusion requiring IPC insertion

Rachelle Asciak - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

A retrospective 1 year analysis of our newly founded Pleural Service

Joy Creaser-Thomas - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Outcomes of an elective day case tunnelled indwelling pleural catheter service

Yasser Madani - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Late Breaking Abstract - Prognostic and therapeutic markers of malignant pleural effusion – The PROMISE study

Ioannis Psallidas - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

A prospective study using serum mesothelin to monitor mesothelioma

David Arnold - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Mesothelioma

N/A

The role of conservative management in traumatic pneumothoraces: an observational study

Steven Walker - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Trauma

N/A

BAP1 expression and treatment outcomes in malignant mesothelioma

Neelam Kumar - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Mesothelioma

N/A

Safety of riociguat for the treatment of pulmonary hypertension: Data from the EXPERT registry

Henning Gall - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Pulmonary arterial hypertension

Riociguat

Copyright © 2026. QuantiNova All rights reserved